Back
Mirati Therapeutics Stock Price Chart
Sponsored
New Year, New Trades, Try A.I. Today
Learn to forecast trends with up to 87.4% proven accuracy -> Register Here
Buy
51
MRTX
Mirati Therapeutics
Last Price:
51.83
Seasonality Move:
-5.31%
7 Day Trial
ALL ACCESS PASS
$
7
Sponsored
Global Leader In Plant Cell Biology Poised For Rapid Growth!
Click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!- The current trend is relatively stagnant and MRTX is experiencing selling pressure, which indicates risk of future bearish movement.
Mirati Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.89 | Buy |
| 20-day SMA: | 45.93 | Buy |
| 50-day SMA: | 55.97 | Sell |
| 200-day SMA: | 64.68 | Sell |
| 8-day EMA: | 49.46 | Buy |
| 20-day EMA: | 47.82 | Buy |
| 50-day EMA: | 52.73 | Sell |
| 200-day EMA: | 71.12 | Sell |
Mirati Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 56.93 | Buy |
| Chaikin Money Flow: | -517111 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.71 - 48.81) | Buy |
| Bollinger Bands (100): | (47.08 - 79.16) | Sell |
Mirati Therapeutics Technical Analysis
| Jan-17 | Jan-18 | Jan-19 | Jan-20 | Jan-23 | Jan-24 | Jan-25 | Jan-26 | Jan-27 | Jan-30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mirati Therapeutics Stock
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 51.81 while MRTX 8-day simple moving average is 48.89, which is a Buy signal.
- The stock price of MRTX is 51.81 while Mirati Therapeutics 20-day SMA is 45.93, which makes it a Buy.
- Mirati Therapeutics 50-day simple moving average is 55.97 while MRTX share price is 51.81, making it a Sell technically.
- MRTX stock price is 51.81 and Mirati Therapeutics 200-day simple moving average is 64.68, creating a Sell signal.
MRTX Technical Analysis vs Fundamental Analysis
Buy
51
Mirati Therapeutics (MRTX)
is a Buy
Is Mirati Therapeutics a Buy or a Sell?
-
Mirati Therapeutics stock is rated a Buy
The current Mirati Therapeutics [MRTX] share price is $51.81. The Score for MRTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Mirati Therapeutics Stock Info
Market Cap:
2.98B
Price in USD:
51.81
Share Volume:
985.96K
Mirati Therapeutics 52-Week Range
52-Week High:
124.81
52-Week Low:
32.96
Buy
51
Mirati Therapeutics (MRTX)
is a Buy
Mirati Therapeutics Share Price Forecast
-
What is the Mirati Therapeutics stock price today?
The Mirati Therapeutics stock price is 51.81 USD today. -
Will MRTX stock go up or go down?
Mirati Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Mirati Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirati Therapeutics is not overvalued.
Is Mirati Therapeutics Stock a Buy?
- Mirati Therapeutics share price is 51.81 while MRTX 8-day exponential moving average is 49.46, which is a Buy signal.
- The stock price of MRTX is 51.81 while Mirati Therapeutics 20-day EMA is 47.82, which makes it a Buy.
- Mirati Therapeutics 50-day exponential moving average is 52.73 while MRTX share price is 51.81, making it a Sell technically.
- MRTX stock price is 51.81 and Mirati Therapeutics 200-day simple moving average is 71.12, creating a Sell signal.
Fundamental Analysis of Mirati Therapeutics
Is Mirati Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $2.53 per share.
Technical Analysis of Mirati Therapeutics
Should I short Mirati Therapeutics stock?
- MRTX Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Mirati Therapeutics is a Sell
- Mirati Therapeutics Relative Strength Index (RSI) is 56.93, which suggest Mirati Therapeutics is overbought
- The Bollinger Bands (25) for Mirati Therapeutics is (41.71 - 48.81), which suggest Mirati Therapeutics is a Sell
- The Bollinger Bands (100) for Mirati Therapeutics is (47.08 - 79.16), which suggest Mirati Therapeutics is a Sell
* Mirati Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.